See every side of every news story
Published loading...Updated

Lungpacer Medical Shares Promising Results from STIMULUS Trial

Summary by MyChesCo
EXTON, PA — Lungpacer Medical has unveiled promising results from its groundbreaking STIMULUS trial, a Phase 1 study conducted in collaboration with Toronto General Hospital. Presented at the 2025 Transcatheter Heart Therapies (THT) conference, the trial explored the use of diaphragm neurostimulation to enhance cardiovascular function in patients on invasive mechanical ventilation. The innovative AeroNova System, central to the trial, combines a…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MyChesCo broke the news in on Friday, February 21, 2025.
Sources are mostly out of (0)